Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-13

Clinical Trial Update: Azithromycin - Ivermectin Mass Drug Administration for Skin Disease [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating azithromycin-ivermectin mass drug administration for skin diseases, including scabies and yaws, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Azithromycin (azithromycin)
  • IVERMECTIN (Ivermectin)

Snippet

Sponsor: London School of Hygiene and Tropical Medicine | Conditions: Scabies, Yaws | Phase 4 | Status: COMPLETED | Results posted: 2019-09-13